A Case of Malignant Pheochromocytoma Treated with 131I-Metaiodobenzylguanidine and CVD Regimen

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

A 44-year-old male had multiple metastasis to the lung, liver, kidney and paraaortic lymphnode from primary adrenal malignant pheochromocytoma. Radiation therapy with 131I-metaiodobenzylguanidine (131I-MIBG), was first performed, which was followed by chemotherapy with cyclophospamide, vincristine and dacarbazine (CVD). A total amount of 4810 MBq of 131I-MIBG was administered then 7 cycles of CVD regimen were added. He was survived for sixteen months with tumor response in primary tumor, paraaortic lymphnode and liver metastasis tumors, in addition to hormonal response. It was considered that the survival was prolonged in spite of advanced case with inoperative primary tumor. © 1994, THE JAPANESE UROLOGICAL ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Ukimura, O., Kojima, M., Hosoi, S., Itoh, H., Watanabe, H., & Minamikawa, T. (1994). A Case of Malignant Pheochromocytoma Treated with 131I-Metaiodobenzylguanidine and CVD Regimen. The Japanese Journal of Urology, 85(5), 811–814. https://doi.org/10.5980/jpnjurol1989.85.811

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free